Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Gepubliceerd in:
1 Nederlandse hepatologie in historisch en toekomstig perspectief hoofdstuk lezen eerste hoofdstuk lezen

2009 | OriginalPaper | Hoofdstuk

16 Levertumoren

Auteurs : Dr. T. Terkivatan, Dr. C. Verhoef, Prof.dr. J.N.M. IJzermans, Dr. R. A. de Man

Gepubliceerd in: Leverziekten

Uitgeverij: Bohn Stafleu van Loghum

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Samenvatting

De diverse diagnostische mogelijkheden die tegenwoordig beschikbaar zijn en het toegenomen gebruik hiervan heeft ertoe geleid dat er steeds vaker focale leverafwijkingen aangetoond worden als toevalsbevinding. Het merendeel van de laesies die buiten een follow-upprogramma van een reeds bekende maligniteit worden ontdekt, zijn benigne van aard.
vorige hoofdstuk 15 Medicamenteus-toxisch leverlijden
volgende hoofdstuk 17 Levercysten
Literatuur
1.
Schwartz LH, Gandras EJ, Colangelo SM, Ercolani MC, Panicek DM. Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology 1999;210:71–74.PubMedCrossRef
2.
3.
Hussain SM, Semelka RC. Hepatic imaging: comparison of modalities. Radiol Clin North Am 2005;43:929–947, ix.
4.
Semelka RC, Martin DR, Balci C, Lance T. Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging 2001;13:397–401.PubMedCrossRef
5.
Helmberger T, Semelka RC. New contrast agents for imaging the liver. Magn Reson Imaging Clin N Am 2001;9:745–766, vi.
6.
Semelka RC, Helmberger TK. Contrast agents for MR imaging of the liver. Radiology 2001;218:27–38.PubMedCrossRef
7.
Regev A, et al. Large cystic lesions of the liver in adults: a 15-year experience in a tertiary center. J Am Coll Surg 2001;193:36–45.PubMedCrossRef
8.
Karavias DD, et al. Simple (non-parasitic) liver cysts: clinical presentation and outcome. Hepatogastroenterology 2000;47:1439–1443.PubMed
9.
Brunt EM. Benign tumors of the liver. Clin Liver Dis 2001;5:1–15, v.
10.
Terkivatan T, Hussain SM, De Man RA, IJzermans JN. Diagnosis and treatment of benign focal liver lesions. Scand J Gastroenterol Suppl 2006:102–115.
11.
Rooks JB, et al. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 1979;242:644–648.PubMedCrossRef
12.
Libbrecht L, et al. Hepatic progenitor cells in hepatocellular adenomas. Am J Surg Pathol 2001;25:1388–1396.PubMedCrossRef
13.
Foster JH, Berman MM. The malignant transformation of liver cell adenomas. Arch Surg 1994;129:712–717.PubMedCrossRef
14.
15.
Terkivatan T, Wilt JH de, Man RA de, IJzermans JN. Management of hepatocellular adenoma during pregnancy. Liver 2000;20:186–187.PubMedCrossRef
16.
Borght S Van Der, Libbrecht L, Katoonizadeh A, Aerts R, Nevens F, Verslype C, Roskams TA. Nuclear b-catenin staining and absence of steatosis are indicators of hepatocellular adenomas with an increased risk of malignancy. Histopathology 2007;51: 855–856.PubMedCrossRef
17.
Terkivatan T, et al. Indications and long-term outcome of treatment for benign hepatic tumors: a critical appraisal. Arch Surg 2001;136:1033–1038.PubMedCrossRef
18.
19.
Mathieu D, et al. Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology 2000;118:560–564.PubMedCrossRef
20.
Sadowski DC, Lee SS, Wanless IR, Kelly JK, Heathcote EJ. Progressive type of focal nodular hyperplasia characterized by multiple tumors and recurrence. Hepatology 1995;21:970–975.PubMedCrossRef
21.
Gaffey MJ, Iezzoni JC, Weiss LM. Clonal analysis of focal nodular hyperplasia of the liver. Am J Pathol 1996;148:1089–1096.PubMedCentralPubMed
22.
Weimann A, et al. Benign liver tumors: differential diagnosis and indications for surgery. World J Surg 1997;21:983–990.PubMedCrossRef
23.
Charny CK, et al. Management of 155 patients with benign liver tumours. Br J Surg 2001;88:808–813.PubMedCrossRef
24.
Terkivatan T, Hussain SM, Lameris JS, IJzermans JN. Transcatheter arterial embolization as a safe and effective treatment for focal nodular hyperplasia of the liver. Cardiovasc Intervent Radiol 2002;25:450–453.PubMedCrossRef
25.
Reddy KR, et al. Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome. Am Surg 2001;67: 173–178.PubMed
26.
Iqbal N, Saleem A. Hepatic hemangioma: a review. Tex Med 1997;93:48–50.PubMed
27.
Terkivatan T, et al. Size of lesion is not a criterion for resection during management of giant liver haemangioma. Br J Surg 2002;89:1240–1244.PubMedCrossRef
28.
Lauffer JM, et al. Biliary cystadenocarcinoma of the liver: the need for complete resection. Eur J Cancer 1998;34:1845–1851.PubMedCrossRef
29.
Semelka RC, Hussain SM, Marcos HB, Woosley JT. Biliary hamartomas: solitary and multiple lesions shown on current MR techniques including gadolinium enhancement. J Magn Reson Imaging 1999;10: 196–201.PubMedCrossRef
30.
Nonomura A, Mizukami Y, Kadoya M. Angiomyolipoma of the liver: a collective review. J Gastroenterol 1994;29:95–105.PubMedCrossRef
31.
Sawai H, Manabe T, Yamanaka Y, Kurahashi S, Kamiya A. Angiomyolipoma of the liver: case report and collective review of cases diagnosed from fine needle aspiration biopsy specimens. J Hepatobiliary Pancreat Surg 1998;5:333–338.PubMedCrossRef
32.
Mahli H, Gores GJ. Review article: the modern diagnosis and therapy of cholangiocarcinoma. Aliment Pharmacol ther 2006; 23:1287–1296.CrossRef
33.
Singhal D, van Gulik TM, Gouma DJ. Palliative management of hilar cholangiocarcinoma. Surg Oncol 2005; 14: 59–74.PubMedCrossRef
34.
Bioulac-Sage P, Laumonier H, Laurent C, Blanc JF, Balabaud C. Benign and malignant vascular tumors of the liver in adults. Semin Liver Dis 2008; 28 (3):302–314.PubMedCrossRef
35.
Lerut J, Weber M, Orlando G, Dutkowski P. Vascular and rare liver tumors: a good indication for liver transplantation? J Hepatol 2007;47: 454–475.CrossRef
36.
Finegold.MJ, Egler RA, Gos JA, Guillerman RP, Karpen SJ, Krishnamurthy R, O’Mahony CO. Liver tumors: pediatric population. Liver Transpl 2008;14: 1545–1556.PubMedCrossRef
37.
Verhoef C, et al. Hepatocellular carcinoma in the Netherlands incidence, treatment and survival patterns. Eur J Cancer 2004;40:1530–1538.PubMedCrossRef
38.
Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC. Increase in primary liver cancer in the UK, 1979-94. Lancet 1997;350:1142–1143.PubMedCrossRef
39.
Stipa F, et al. Outcome of patients with fibrolamellar hepatocellular carcinoma. Cancer 2006;106:1331–1338.PubMedCrossRef
40.
Libbrecht L, et al. Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl 2002;8:749–761.PubMedCrossRef
41.
Verhoef C, Valkema R, Man RA de, Krenning EP, Yzermans JN. Fluorine-18 FDG imaging in hepatocellular carcinoma using positron coincidence detection and single photon emission computed tomography. Liver 2002;22:51–56.PubMedCrossRef
42.
Trevisani F, et al. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti- HCV status. J Hepatol 2001;34:570–575.PubMedCrossRef
43.
Durand F, et al. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J Hepatol 2001;35:254–258.PubMedCrossRef
44.
Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999;19:329–338.PubMedCrossRef
45.
Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators. Hepatology 2000;31: 840–845.CrossRef
46.
Verhoef C, et al. Good outcomes after resection of large hepatocellular carcinoma in the non-cirrhotic liver. Dig Surg 2004;21:380–386.PubMedCrossRef
47.
Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 2005;25:181–200.PubMedCrossRef
48.
49.
Mazzaferro V, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693–699.PubMedCrossRef
50.
Llovet JM, Schwartz M, Fuster J, Bruix J. Expanded criteria for hepatocellular carcinoma through downstaging prior to liver transplantation: not yet there. Semin Liver Dis 2006;26:248–253.PubMedCrossRef
51.
Adam R, et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg 2003;238:508–518.PubMedCentralPubMedCrossRef
52.
Jansen MC, et al. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review. Eur J Surg Oncol 2005;31:331–347.PubMedCrossRef
53.
Chen MS, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006;243:321–328.PubMedCentralPubMedCrossRef
54.
Huang GT, et al. Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. Ann Surg 2005;242:36–42.PubMedCentralPubMedCrossRef
55.
Yoshida H, et al. Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C. Gut 2004;53:425–430.PubMedCentralPubMedCrossRef
56.
57.
58.
59.
Ben Menachem T. Risk factors for cholangiocarcinoma. Eur J Gastroenterol Hepatol 2007;19:615–617.PubMedCrossRef
60.
Miller G, Schwartz LH, D’Angelica M. The use of imaging in the diagnosis and staging of hepatobiliary malignancies. Surg Oncol Clin N Am 2007;16:343–368.PubMedCrossRef
61.
Bipat S, et al. Evidence-base guideline on management of colorectal liver metastases in the Netherlands. Neth J Med 2007;65:5–14.PubMed
62.
Joosten J, Ruers T. Local radiofrequency ablation techniques for liver metastases of colorectal cancer. Crit Rev Oncol Hematol 2007;62:153–163.PubMedCrossRef
63.
Cummings LC, Payes JD, Cooper GS. Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer 2007;109:718–726.PubMedCrossRef
64.
65.
Poon RT, et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg 2004;240:698–708.PubMedCentralPubMed
66.
Gollub MJ, Schwartz LH, Akhurst T. Update on colorectal cancer imaging. Radiol Clin North Am 2007;45: 85–118.PubMedCrossRef
67.
Adam R, et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 2004;240:1052–1061.PubMedCentralPubMedCrossRef
68.
Pawlik TM, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005;241:715–722, discussion.
69.
Abdalla EK, et al. Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 2006;13:1271–1280.PubMedCrossRef
70.
Clavien PA, Petrowsky H, DeOliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 2007;356:1545–1559.PubMedCrossRef
71.
Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg 2007;84:324–338.PubMedCrossRef
72.
Jaeck D. The significance of hepatic pedicle lymph nodes metastases in surgical management of colorectal liver metastases and of other liver malignancies. Ann Surg Oncol 2003;10:1007–1011.PubMedCrossRef
73.
Jain S, Sacchi M, Vrachnos P, Lygidakis NJ, Andriopoulou E. Recent advances in the treatment of colorectal liver metastases. Hepatogastroenterology 2005; 52:1567–1584.PubMed
74.
Leen E, Horgan PG. Radiofrequency ablation of colorectal liver metastases. Surg Oncol 2007;16:47–51.PubMedCrossRef
75.
Punt CJ. [Medicamenteuze behandeling van patiënten met colorectumcarcinoom]. Ned Tijdschr Geneeskd 2005;149:1441–1447.PubMed
76.
Adam R, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004; 240:644–657.PubMedCentralPubMedCrossRef
77.
Adam R, et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 2001;8:347–353.PubMedCrossRef
78.
D’Angelica M, et al. Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study. Ann Surg Oncol 2007;14:759–765.PubMedCrossRef
Metagegevens
Titel
16 Levertumoren
Auteurs
Dr. T. Terkivatan
Dr. C. Verhoef
Prof.dr. J.N.M. IJzermans
Dr. R. A. de Man
Copyright
2009
Uitgeverij
Bohn Stafleu van Loghum
Boek
Leverziekten

Print ISBN: 978-90-313-7436-6

Elektronisch ISBN: 978-90-313-7437-3

Copyright: 2009

DOI
https://doi.org/10.1007/978-90-313-7437-3_16